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Contribution of intraneuronal amyloid β accumulation to Alzheimer's disease
Intraneuronal accumulation of amyloid β (Aβ) has been identiﬁed as a component in the pathophysiology of Alzheimer's disease and is
suggested to occur early in disease. However, a variety of mechanistic questions remain unanswered. For example, Aβ oligomersmay be taken up
into neurons or generated intracellularly. The mechanisms of oligomerization in each scenario are not yet deﬁned as well as any similarities or
differences on cellular function or viability and the relevance of each to disease.
We invite you to submit an article for a special issue of Life Science focusing exclusively on the myriad aspects of intraneuronal Aβ
accumulation and its consequence as a component of Alzheimer's disease. This issuewill provide an opportunity for a concentrated assessment of
the ﬁeld from laboratory interests ranging from biochemical analysis of oligomerization to histologic detection of intraneuronal Aβ. Topics of
interest include but are not limited to:• Mechanisms of Aβ uptake by neurons
• Mechanisms of formation and accumulation of Aβ in neurons
• Staging of intraneuronal Aβ accumulation and disease course
• Consequences and mechanisms of intraneuronal Aβ accumulation
• Strategies targeting intraneuronal Aβ accumulation
• Models for studying intraneuronal Aβ
• Imaging and/or detection of intraneuronal AβManuscripts should adhere to the author guidelines for Life Sciences located at the following link: http://www.elsevier.com/wps/ﬁnd/
journaldescription.cws_home/525477/authorinstructions. All papers should be submitted under the Article Type Name “SI: Intraneuronal Aβ”.
The following timeline is expected for all prospective authors:Date 1st submission expected December 1, 2011
Manuscript submission deadline January 15, 2012
Expected date when all manuscripts are fully refereed and revised May 15, 2012
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